Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Opiate Sparing Pain Management Protocol After ACL Reconstruction
NCT06561035Phase 3Enrolling by invitation
- Sponsor
- Campbell Clinic Orthopaedics
- Start
- Sep 2024
- Primary completion
- Dec 2027
- Modality
- Orthosteric Ligands
- Countries
- 1
01
Overview
Phase 3, randomised trial of methylprednisolone in postoperative pain, sponsored by Campbell Clinic Orthopaedics. Primary endpoints: Visual Analog Scale at 12 weeks and Oral Morphine Equivalent at 12 weeks. Started Sep 2024; status: enrolling by invitation.
02
Drugs
methylprednisolone
03
Conditions
postoperative pain
Beyond the preview
Go deeper on NCT06561035.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06561035.